Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study).

Anna CandoniFrancesca FarinaKatia PerruccioRoberta Di BlasiMarianna CriscuoloChiara CattaneoMario DeliaMaria Elena ZannierGiulia DragonettiRosa FanciBruno MartinoMaria Ilaria Del PrincipeLuana FianchiNicola VianelliAnna ChierichiniMariagrazia GarziaGiuseppe PetruzzellisGianpaolo NadaliLuisa VergaAlessandro BuscaLivio Pagano

Published in: Mycoses (2020)

These data show that IA during first induction CHT can delay the subsequent therapeutic program and has a significant impact on OS, specifically in AML patients who did not achieved a CR of AML with the first course of CHT.

Keyphrases

acute myeloid leukemia
liver failure
allogeneic hematopoietic stem cell transplantation
bone marrow
electronic health record
dendritic cells
quality improvement
respiratory failure
immune response
mesenchymal stem cells
acute lymphoblastic leukemia
cell therapy
acute respiratory distress syndrome